Ryman Healthcare Limited presents a robust financial outlook with a focus on strategic improvements in cash flow and operational efficiency. The company is targeting a $150 million improvement in cash flow from existing operations (CFEO) by FY29 and has already achieved $47 million of this target. Ryman plans a $500 million cash release through stock sell-downs and land sales by FY29. The company maintains a scalable portfolio with 47 retirement villages and aims for low capital intensity through strategic divestments. FY26 showed significant improvements with operating EBITDAF nearly doubling due to cost control and revenue growth, while maintaining financial flexibility through a new capital management framework.
Key Points
Ryman Healthcare Limited aims for a $150 million CFEO improvement by FY29, with $47 million already achieved in FY26.
The company plans to deliver $500 million in cash release from stock sell-down and land sales between FY26 and FY29.
Ryman has a scalable portfolio with 47 retirement villages across New Zealand and Australia, emphasizing premium locations and integrated care.
FY26 saw a significant improvement in operating EBITDAF, which nearly doubled from FY25, mainly due to disciplined cost control and revenue growth.
Ryman's financial strategy includes a new capital management framework to maintain a low gearing ratio and secure funding flexibility.
The company has adjusted its development strategy, focusing on reducing capital intensity and divesting non-essential properties.
FY26 financial results showed strong cash flow from development activities, contributing to a free cash flow of $188.3 million.
Ryman continues to optimize its care and village operations to enhance profitability and meet strategic financial targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.